Supplement Table I
Sequences of primers and probes for TaqMan Model 3: adjusted for age, gender, coronary artery disease (none CAD, stable CAD, unstable CAD, NSTEMI, STEMI), the use of lipid-lowering drugs, body mass index, type 2 diabetes, hypertension, smoking status, eGFR (CKD-EPI), LDL-C, HDL-C, and triglycerides Model 4: Model 3 additionally adjusted for hsTnT Model 5: Model 3 additionally adjusted for NT-proBNP Model 1 and 2 are shown in Table 5 Supplement Table V Hazard ratios for death from all causes according to HDL-cholesterol, apolipoprotein A-I and MPO concentrations 
